ECM – Eye Health News

Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline BERLIN and SAN FRANCISCO—Bayer and Perfuse Therapeutics Inc. have announced an agreement under which Bayer said it will fully acquire Perfuse Therapeutics, a biopharmaceutical company pioneering research into ischemia-induced ocular diseases.

Science Gets Closer to Understanding How a Psychedelic Trip Changes the BrainA single psychedelic trip may cause physical changes in the brain that could explain why some people report psychological benefits from the experience, a small study suggests. The research, published in Nature Communications, focused on psilocybin, the psychedelic compound found in so-called magic mushrooms.

Report Raises Alarm About Widespread Tanning Myths Ahead of SummerMisinformation about sunscreen and sun safety is driving millions of Americans to abandon basic skin protection, increasing their risk of skin cancer, according to new data from the American Academy of Dermatology.

A Mother’s Day Tribute to Working Moms in OpticalThe journey to achieving a healthy work-life balance is difficult for most individuals today, but it presents a particularly demanding path for working mothers. Those challenges are met daily by working moms within the optical community, with female ODs embracing an expanding role in eyecare while navigating the equally challenging role of parenthood. In honor…

Does Vaping Cause Cancer?A scientific review has raised fresh concerns about the long-term cancer risks of vaping, concluding that e-cigarettes are probably carcinogenic, while also acknowledging significant gaps in the evidence. The analysis of reviews and single studies published since 2017 concluded that nicotine vaping “likely” contributes to oral and lung cancers. But the actual risks and how…

Warby Parker Sees Growth in First Quarter, Reaffirms Full-Year GuidanceNEW YORK—Warby Parker Inc. (NYSE: WRBY) has announced financial results for the first quarter ended March 31, 2026, reporting $242.4 million in revenue, a year-over-year increase of $18.7 million, or 8.3 percent. The company also reported that the first quarter generated net income of $3.2 million, with adjusted EBITDA rising to $29.6 million, exceeding the…

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales OutlookALISO VIEJO, Calif.—RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company focused on improving vision after cataract surgery, on Wednesday announced financial results for the quarter ended March 31, 2026. In the first quarter of 2026, the company reported sales of $30.9 million, down 18.5 percent compared with the same period in 2025, which RxSight said…

The Vision Council Testifies at USTR Hearings, Urges Exclusion of Eyewear and Optical Products From Possible Tariff ActionsALEXANDRIA, Va.—The Vision Council announced this week that Omar Elkhatib, director of government relations, testified on behalf of the group and its members on May 5 at a public hearing held at the U.S. International Trade Commission in Washington, D.C.

Sight Sciences Financial Results for Q1 2026 Show GrowthMENLO PARK, Calif.—Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company, has reported financial results for the first quarter ended March 31, 2026. In Q1, revenue was $19.7 million, an increase of 13 percent compared with the same period in the prior year.

EyePoint Announces First Quarter 2026 Revenue ResultsWATERTOWN, Mass.—EyePoint, Inc. (Nasdaq: EYPT), a clinical-stage biopharmaceutical company developing therapeutics for retinal diseases, announced financial results for the first quarter ended March 31, 2026, and highlighted recent corporate developments.

SUNY Optometry 2026 Commencement to Feature Microsoft’s David C. Rhew, MD, as Keynote Speaker, Will Recognize Three HonoreesNEW YORK—SUNY College of Optometry has announced that its 2026 Commencement Ceremony, which will be held on Thursday, May 21, will feature a keynote address from David C. Rhew, MD, global chief medical officer and vice president of health and life sciences at Microsoft. In addition, the ceremony will recognize recipients of the college’s Presidential…

New ALS Drug Stabilizes Decline With Improved Strength, Mobility for SomeHistorically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline of neurological function that eventually robs them of the ability to move, speak, eat or breathe. Now, researchers from Washington University School of Medicine in St. Louis and collaborators report that long-term use of tofersen delays symptom progression and death and in about one-quarter…

Can Migraine Drugs Guard Against Glaucoma? CGRP Inhibitors Show PromisePeople who used calcitonin gene-related peptide (CGRP) inhibitor drugs to prevent migraine had a lower risk of glaucoma, a retrospective study showed. Among 74,000 migraine patients, those taking CGRP inhibitors for migraine prevention had a 25 percent lower risk of incident glaucoma within 3 years compared with those using other migraine prophylaxis (HR 0.75, 95…

Alcon Reports First Quarter Growth Boosted by New Product LaunchesGENEVA—Alcon (SIX/NYSE:ALC), a global leader in eyecare, announced its financial results for the three months ending March 31, 2026. For the first quarter of 2026, sales were $2.7 billion, up 10 percent on a reported basis and up 6 percent on a constant currency basis, as compared with the same quarter of the previous year.…

VSP Vision Releases 2025 Impact Report, Marks New Milestone as VSP Eyes of Hope Helps More Than 4.5 Million PeopleRANCHO CORDOVA, Calif—Today, VSP Vision announced it has released its 2025 Impact Report, detailing progress toward its corporate social responsibility (CSR) commitments and its continued focus on accelerating health equity, advancing sustainability and empowering inclusion. The report spotlights how—in collaboration with network providers, community partners and employees—VSP Eyes of Hope has helped more than 4.5…

The Exchange 2026 Gathers Nearly 4,000 in Nashville as Vision Source Celebrates Its 35th AnniversaryNASHVILLE, Tenn.—Vision Source, a North American network of independent private practice optometrists, wrapped up The Exchange 2026 last week, where it welcomed nearly 4,000 doctors, staff members, and vendor partners to Nashville and celebrated 35 years in support of independent optometry. This year’s event “reinforced Vision Source’s continued commitment to innovation, collaboration and practice growth,”…

OPTYX New York Inaugurates 13th Location, Launches Gift of Sight Community Eyecare InitiativePORT WASHINGTON, N.Y.—OPTYX New York will celebrate the grand opening of its new Port Washington, N.Y. location today, Thursday, May 7, 2026, alongside the launch of Gift of Sight, the company’s new community initiative developed in partnership with local school districts and nurses.

Ocular Therapeutix Releases 2026 First Quarter Revenue ResultsBEDFORD, Mass.—Ocular Therapeutix Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company in the retina space, reported financial results for the first quarter ended March 31, 2026, and provided recent business highlights. Ocular Therapeutix reported total cash and cash equivalents of $666.7 million as of March 31, 2026. Based on current plans and anticipated cash inflows…

New Trend Report Reveals 93 Percent of Small Businesses Expect Growth in 2026CHICAGO—Small businesses are maintaining strong momentum in 2026, with sustained confidence in growth, increasing use of AI and continued reliance on flexible financing options, according to the latest Small Business Cash Flow Trend Report from OnDeck, a leader in small business lending, and Ocrolus, an AI workflow and cash flow analytics platform for lenders.

6 Questions to Ask Your Doctor Before Starting a Mental Health DrugThe prospect of starting a new drug to treat a mental health condition can feel both hopeful and daunting. On the upside, you may feel encouraged about the possibility of finding a treatment that will help you feel and function better. But you may also be concerned about whether it will actually work for you…

Large TB Outbreaks in the United States Decline Slightly in Recent Years, CDC ReportsLarge tuberculosis (TB) outbreaks in the United States decreased slightly in recent years and disproportionately affected socially and economically vulnerable populations, according to a report in Morbidity and Mortality Weekly Report.

Zyloware-Kenmark Invites ECPs to Celebrate National Eyewear Day on June 6PORT CHESTER, N.Y.—Zyloware-Kenmark Eyewear invites all eyecare professionals and eyewear enthusiasts to once again join in the celebration of National Eyewear Day on Saturday, June 6, 2026, one month from today. This year marks the 10th annual National Eyewear Day celebration, Zyloware-Kenmark said. Each year on June 6, Zyloware-Kenmark promotes tips, tools and philanthropic initiatives…

EyeCare4Kids Partners With Xenon Ophthalmics to Expand Access to Comprehensive Vision ExamsSALT LAKE CITY—EyeCare4Kids, a Utah-based nonprofit that provides vision screenings, eye exams and prescription eyeglasses to underserved children and families, has announced a strategic partnership with Xenon Ophthalmics, a New Jersey–based medical technology company, to expand access to comprehensive vision care in underserved communities. As part of the collaboration, the announcement said Xenon Ophthalmics will…

The Canadian Association of Optometrists Celebrates Vision Health Month With an Online Campaign Encouraging Canadians to ‘GetEyeWise’OTTAWA—As the national voice of optometry, the Canadian Association of Optometrists (CAO) announced it remains committed to using Vision Health Month to raise awareness about the importance of regular, comprehensive eye exams.

Women In Optometry’s 8th Annual Women’s Leadership Conference Is Scheduled for September 29NEWARK, N.J.—Women In Optometry (WO) has announced that its 8th annual Women’s Leadership Conference will be held on Tuesday, September 29, 2026, from 4:00-6:45 p.m., within the 2026 American Academy of Optometry (AAO) Annual Meeting in Anaheim, Calif.

West Virginia University Raises Awareness About Vision Impairment for May’s Healthy Vision MonthMORGANTOWN, W. Va.—As part of May’s Healthy Vision Month, West Virginia University (WVU) has announced its assistant professor Heather Livengood is raising awareness about the effects of vision impairment experienced by more than 37 million adults in the United States.

Vision-Correction Procedure Linked to Higher Level of Neuroticism TraitsAdults opting for small incision lenticule extraction (SMILE) surgery to improve vision exhibited increased levels of neuroticism, which could have implications for counseling and patient satisfaction, investigators in a study from Hong Kong concluded.

Social Media Videos, Easy Access Raise Risk of Teen Inhalant UseNew research is raising alarms about inhalants, which are often portrayed online as harmless while putting teens at real risk. Two new studies point to a troubling pattern: Younger teens, especially girls, may be more vulnerable—and social media is a major source of exposure.

Federal Student Loan Limits Finalized, Optometry Recognized as Professional ProgramWASHINGTON, D.C.—The U.S. Department of Education finalized regulations on April 30 that include updated borrowing limits on federal and student loans for both graduate and professional degrees, as well as changes to student loan forgiveness and repayment options. According to the new regulations, part of the Trump administration’s Working Families Tax Cuts Act that was…

Lighthouse Guild Appoints Kathryn Webster to Its Board of DirectorsNEW YORK—Lighthouse Guild has announced the appointment of Kathryn Webster to its board of directors, effective immediately. Webster brings a rare combination of financial acumen, civic leadership, and lived experience as a blind professional.

Americans Aren't Sleeping Enough. Here's What Could HelpAdults should be getting at least seven hours of sleep each night, according to the American Academy of Sleep Medicine. "Below that, there's clear evidence that you're going to feel lethargic during the day," says James Rowley, a pulmonologist and the program director of the Sleep Medicine Fellowship at Rush University Medical Center, as well…

FDA Approves 1st Non-Anti-Psychotic Medication for Agitation in Alzheimer's DiseaseThe Food and Drug Administration (FDA) approved the drug Auvelity for the treatment of agitation in adults with Alzheimer's dementia. The extended-release tablet is the first FDA-approved medication for this condition that is not an anti-psychotic.

GLP-1 Drugs May Modestly Raise Optic Neuropathy Risk in T2DA large cohort study found that the use of GLP-1 receptor agonists (GLP-1 RAs) over 3 years was associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION) compared with the use of SGLT2 inhibitors in veterans with type 2 diabetes (T2D).

IDOC Launches Clerra, a Comprehensive Ophthalmic Lens Range Designed to Simplify Dispensing and Deliver ValueTRUMBULL, Conn.—IDOC, a privately held U.S. alliance for independent optometrist business owners, has announced the launch of Clerra, a new ophthalmic lens range exclusively available through IDOC Labs. Built around simplicity, Clerra helps practices streamline dispensing conversations and increase capture rate while saving at least 25 percent on typical lab bills, based on an analysis…

American Optometric Association Congratulates Winners of 2026 AwardsALEXANDRIA, Va.—The American Optometric Association (AOA) has announced and is congratulating winners of its 2026 awards. In making the announcement, the AOA said it is proud to honor several of its members with prestigious awards across multiple categories including the AOA Excellence Awards, Paraoptometric Awards and more from the AOA Foundation. Winners of the awards…

Menicon Marks 75th Anniversary, Looks to Future InitiativesNAKA-KU, Japan—Menicon Co., Ltd, a global contact lens manufacturer, announced the celebration of its 75th anniversary in February 2026 and advised that it will implement various initiatives over the one-year period from February 8, 2026 to February 5, 2027.

Southern College of Optometry to Award Two Honorary Degrees at 2026 Optometry CommencementMEMPHIS, Tenn.—Southern College of Optometry has announced it will bestow two honorary degrees as part of its 2026 commencement ceremony to Lynn T. Shaw Sr. and Jarrett Johnson, OD. Shaw will receive the honorary doctor of humane letters, and Dr. Johnson will receive the honorary doctor of ocular science.

Cases of Highly Contagious Rotavirus Increasing Among Children, Pittsburgh Doctor SaysAllegheny Health Network chair of pediatrics Dr. Joseph Aracri said cases of the highly contagious rotavirus among local children are increasing. The uptick usually happens every year, but the increase is usually in February and March.

Brain Changes Linked to Ultraprocessed Foods, Even in Otherwise Healthy DietsPeople who included more ultraprocessed foods—chips, candy bars, frozen meals, sugary cereals or soda, for example—in an otherwise healthy diet had worse attention scores and a higher risk of dementia, an analysis of cross-sectional data in Australia suggested.

Fielmann Group Reports Record FY2025 Financial Results, Growth in First Quarter of 2026HAMBURG, Germany—Global eyewear provider the Fielmann Group (ETR: FIE) announced it has concluded its Vision 2025 growth strategy with FY2025 results in line with guidance and the preliminary figures published in February. In making the announcement, the company reported an increase in consolidated sales of 7.4 percent year-over-year to €2.435 billion compared with €2.267 billion…

Hoya Achieves Revenue Growth in 2025’s Fourth Quarter and Full-YearTOKYO—Hoya Corporation (7741:Tokyo) has announced consolidated revenue of 248.1 billion yen for the fourth quarter ended March 31, 2026, up 15 percent from the previous year, and up 9 percent on a constant currency basis.

Vision Care Spending Edged Downward in Q1 2026, The Vision Council’s Consumer inSights Report ShowsALEXANDRIA, Va.—The Vision Council has released its Consumer inSights Q1 2026 report, which offers a detailed look at U.S. consumer behavior across optical products and services for the first quarter of 2026.

Nominate a Supportive Business Partner for the Vision Monday and 20/20 Magazine 2026 'Ultimate Partners' ProgramNEWARK, N.J.—The readers of Vision Monday and 20/20 magazine are being asked once again to share nominations for their Ultimate Partners. The deadline for submissions is June 5. Now in its sixth year, Jobson’s 2026 Ultimate Partners program allows readers to highlight their great business support partners and showcase their assistance. Open to all eyecare…

Review of Ophthalmology: MIGS and Mingle—Combining With Cataract SurgeryTo some, minimally invasive glaucoma surgery is increasingly viewed as an essential component of patient care, providing an opportunity for reduced reliance on topical medications and improved quality of life. Particularly, when combined with cataract surgery, MIGS can expand those benefits to a wider range of patients and helps ease the burden on glaucoma specialists.…

The Truth Behind 7 Common Lung Cancer MythsLung cancer kills more Americans than any other form of cancer: more than prostate cancer and colon cancer combined, and nearly three times as many as breast cancer. But while pink ribbons are a familiar sight and 4 in 5 women get their recommended mammograms, screening for lung cancer is far less common. It’s often…

Scientists Rethink How Much Lifespan Is in Our ControlAs interest in longevity grows, researchers are revisiting a long-running question: How much of lifespan is under our control? For decades, the consensus held that lifestyle and environment were the primary drivers of aging. But that view is being re-examined as new analyses suggest the genetic contribution may have been underestimated.

Bausch + Lomb Reports First Quarter 2026 Revenue Growth Across Key Brands, Raises Full-Year GuidanceVAUGHAN, Ontario—Global eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) yesterday announced its first quarter 2026 financial results and raised its 2026 guidance. Total reported revenue was $1.244 billion for the first quarter of 2026, as compared with $1.137 billion in the first quarter of 2025, an increase of $107 million, or 9 percent.…

New Contact Lens Update Spotlights the Benefits of Prescribing Contact Lenses for ChildrenWATERLOO, Ontario—The Centre for Ocular Research & Education (CORE) has published Issue 89 of Contact Lens Update, which focuses on contact lenses for a rapidly growing demographic in eyecare practices: the pediatric population. “Contact lenses are being increasingly prescribed to younger patients,” said Jill Woods, head of clinical research at CORE. “They can positively impact…

Glaukos Announces 41 Percent First Quarter Sales Increase Fueled by Two TreatmentsALISO VIEJO, Calif.—Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company, yesterday released its first quarter financial results for the period ending March 31, 2026.

Sterling Optical to Offer Complimentary Eye Exams to Certified Baseball Umpires for 2026 SeasonNEW YORK—Emerging Vision, Inc. and its retail brand Sterling Optical announced they have launched a complimentary comprehensive eye exam promotion for certified baseball umpires at participating locations throughout the 2026 season.

April-May Issue of Vision Monday Examines State of Private Equity and Practice Transitions in 2026NEWARK, N.J.—Vision Monday’s April-May cover story, which focuses on the current state of the private equity (PE) landscape within the optical industry, details key trends in mergers and acquisitions (M&A), with experts predicting a significant rebound in global PE dealmaking for 2026.

AI Tool May Help Identify ADHD in Kids Long Before Typical DiagnosisAttention-deficit/hyperactivity disorder, or ADHD, affects millions of children, but many go years without a diagnosis, missing the chance for early support. Now, a new study from Duke Health, published April 27 in the journal Nature Mental Health, suggests artificial intelligence could help change that.

Rheumatic Disease Drugs Help COVID Virus Stick Around Longer, Study SuggestsDrugs commonly used to treat systemic autoimmune rheumatic diseases (SARDs) may keep the SARS-CoV-2 circulating after COVID-19 infection in patients with these conditions, with researchers documenting substantially increased viral antigen persistence compared with other post-COVID patients.

Private Equity and Practice Transitions in 2026After a sluggish start to 2025, global private equity (PE) dealmaking gained traction late last year, setting the stage for what is projected by experts to be a strong rebound in 2026 across various sectors. Despite persistent economic uncertainties, including tariffs, general economic conditions, and global tensions, private equity enters 2026 with renewed optimism, experts…

Kentucky Board of Optometric Examiners Forms Workgroup, Tightens Renewal Testing, But National Groups Say Gaps RemainNEWARK, N.J.—What started as temporary, pandemic-era adjustments by the Kentucky Board of Optometric Examiners (KBOE) to reduce student travel and in-person testing has become an extended licensing dispute within the Kentucky optometric community. The controversy, which centers on reports that 21 optometry graduates were licensed between 2020 and 2023 without having passed one or more…

United Opticians Association Leadership Conference Slated for June 25-27 in ChicagoLEXINGTON, Ky.—The United Opticians Association’s (UOA) One Vision | One Voice | One UOA Leadership Conference will be held on June 25-27, 2026 in Chicago at the Hilton Rosemont/Chicago O’Hare, according to an announcement from the UOA. The three-day event will bring together hundreds of changemakers, educators, and advocates who are shaping the future of…

EssilorLuxottica Shareholders Approve All Board Resolutions at Annual General MeetingPARIS—At EssilorLuxottica’s (Reuters: ESLX.PA) annual general meeting yesterday, shareholders approved all 30 resolutions submitted by the board of directors, including the distribution of a €4.00 dividend per share for the financial year 2025 and more.

EyeCare4Kids Joins Annual UTAHGIVES Fundraiser to Expand Free Vision Care for Utah ChildrenMIDVALE, Utah—EyeCare4Kids, a Utah-based nonprofit that provides vision care to underserved children and families, has announced it is participating in UTAHGIVES, Utah’s new 24-hour statewide day of giving scheduled for Thursday, April 30, 2026.

As Heart, Kidney and Metabolic Health Worsen, Cancer Risk May Rise: StudyAs heart, kidney and metabolic problems progress to more advanced stages, a person's risk of developing several cancers also rises sharply, a new study finds. Cardiovascular-kidney-metabolic (CKM) syndrome is a disorder that occurs when heart disease, kidney problems and metabolic issues including obesity and diabetes all happen together, according to the American Heart Association.

Patients Say They Want Alzheimer's Blood Tests. Doctors Aren't Sure They Help.The idea is straightforward: Take a blood test now, even without symptoms, and learn if you could some day develop Alzheimer’s disease. Whether you should get this test is a more complicated matter.

AI Skin Cancer Apps: Do They Work?An AI-based skin assessment app may drive up healthcare visits for benign lesions, with unclear benefits for skin cancer detection, a Dutch clinical trial has found. The trial, of nearly 20,000 patients in one health insurance plan, found that those given free access to the app were no more likely to be diagnosed with skin…

VSP Vision Exam Rebate Through PECAA Surpasses $100 Million, Program Is Extended Through 2027BOCA RATON, Fla. and RANCHO CORDOVA, Calif.—Professional Eye Care Associates of America (PECAA) and VSP Vision have announced that the VSP Vision Exam Rebate will be extended through 2027, enabling PECAA Max members to continue receiving up to $15 per VSP commercial eye exam. Since its launch, the rebate has provided more than $100 million…

Smart Glasses on the Horizon for AppleNEWARK, N.J.—Apple is reportedly testing a set of camera-equipped, display-free smart glasses designed to extend Siri and iPhone functionality to eyewear. Based on reporting from Bloomberg and Forbes, the project at Apple is internally code-named N50 and the devices are aimed at everyday usage, including features like photo and video capture, phone calls, music and…

World Council of Optometry and Alcon Video Series Summarizes TFOS DEWS III ReportST. LOUIS—The World Council of Optometry (WCO) and Alcon have released a three-part video series to help ECPs understand and apply recommendations from the recently published Tear Film & Ocular Surface Society Dry Eye Workshop III (TFOS DEWS III) report.

Outlook Therapeutics Reports Closing of $5.0 Million Registered Direct OfferingISELIN, N.J.—Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the treatment of retina diseases, has announced the closing of a registered direct offering of 16,129,033 shares of common stock at $0.31 per share.

Prevent Blindness Names May Inherited Retinal Disease and Genetic Testing Awareness MonthCHICAGO—Prevent Blindness, a nonprofit eye health organization, has designated May as its third annual Inherited Retinal Disease (IRD) and Genetic Testing Month. Prevent Blindness offers a variety of free, expert-approved resources on IRDs.

A Record-Breaking Measles Outbreak in the U.S. Has Ended. It May Have Helped Drive Vaccination RatesThe measles outbreak in South Carolina—the largest the United States has had in decades—has ended, state health officials announced Monday. There were nearly 1,000 confirmed cases over about six months, including at least 21 hospitalizations.

U.S. Doctors Warn of a Potentially Bad Year for Tick-Borne DiseasesTick season seems to be off to a fast start, with an unusually high number of bites already reported across the country. Some U.S. doctors are worried about the potential for a bad year for tick-borne diseases.

EssilorLuxottica Acquires Faro to Advance Technologies in Eyewear ManufacturingPARIS—EssilorLuxottica (Reuters: ESLX.PA) has announced the acquisition of Faro, an Italian company with more than 20 years of expertise in the design, manufacture and distribution of high-precision, computer numerical control (CNC) machinery for milling and diamond cutting, serving the jewelry and eyewear industries. Based in Santa Maria di Sala, Venice, in the region of Italy’s…

Prevent Blindness to Kick Off Its Focus on Eye Health Webinar Series Around the Theme of ‘Powering Partnerships to Advance Eye Health’CHICAGO—Prevent Blindness, a nonprofit eye health organization, has announced it is kicking off the first webinar in its Focus on Eye Health Webinar Series on May 19, 2026. This year’s theme is “Powering Partnerships to Advance Eye Health.”

Theialife Appoints Thomas Ruggia as President and CEO to Help Advance Oral Myopia TherapyDOVER, Del.—Theialife, a late-stage clinical company advancing therapeutic solutions for ocular diseases, has announced the appointment of Thomas Ruggia as the company’s first president and CEO.

Reflecting on Earth Day 2026: A Focus on Sustainability in OpticalNEWARK, N.J.—Throughout the world on April 22, communities, businesses and individuals celebrated Earth Day 2026, a day of mindfulness and international cooperation dedicated to building awareness and supporting protections for the environment. Within the optical industry, support for environmental initiatives has been widespread and has taken many shapes, and years of progress, whether through more…

Gene Therapy for a Rare Type of Deafness Shows Lasting ResultsAn experimental gene therapy appears safe and highly effective for restoring hearing to people born with a rare form of deafness, researchers reported last week. The study, the largest and longest to date to evaluate a gene therapy for hearing loss, provides powerful new evidence that the approach may provide the first way to restore…

Better Overall Sleep Associated With Lower Pneumonia RiskA composite measure of healthy sleep—which captured not just how long people sleep but how well and how consistently—is associated with a substantially lower risk of pneumonia, according to a long-term cohort study published last week in Open Forum Infectious Diseases.

EssilorLuxottica Celebrates Climate-Related Milestones in Latest Report, Launches Sustainability WeekPARIS—EssilorLuxottica this week published its 2025 Sustainability Report and announced that it launched EssilorLuxottica Sustainability Week, inviting its employees, stakeholders and customers to make a difference for the planet aligned with the Earth Day theme, “Our Power, Our Planet.” The company said caring for the planet is a shared responsibility and that its Eyes on…

Eyoto Appoints Tony Veverka as Interim CEO, Looks to Expand U.S. PresenceBIRMINGHAM, U.K.—Eyoto, a medtech company focusing on teleoptometry, announced it has named Tony Veverka as its new interim CEO. Veverka has served as a board advisor for Eyoto since 2025 and according to the company he brings extensive experience in the medtech and health care industries to the role. Veverka has held senior leadership roles…

Sight Sciences Issues 2025 Sustainability Report on ESG InitiativesMENLO PARK, Calif.—Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company, has published its Sustainability Report, highlighting the company’s sustainability activities, performance and results from the last three years.

Southern College of Optometry Recognizes Three Alumni With Private Practice AwardsMEMPHIS, Tenn.—The Southern College of Optometry (SCO) announced it awarded three alumni on April 8 with the Hayes Center for Practice Excellence Award, which recognizes a graduate of the past 10 years who owns and operates a private optometry practice.

BVI’s Virtuoso Receives CE Mark Under EU Medical Device RegulationWALTHAM, Mass.—BVI, a global leader in ophthalmic device innovation, has announced that its product Virtuoso has received the CE Mark under the European Union Medical Device Regulation (EU MDR), enabling commercialization across markets recognizing the CE Mark.

AI in Eye Care: The AI-Powered Eyecare Clinic—A Blueprint for Efficiency and Enhanced Patient CareEyecare has a data problem. Not a shortage of it—quite the opposite. Patient histories, prior imaging, treatment timelines, clinical notes: the information is there. What’s been missing is any reliable way to make it useful in real time—at the pace a busy clinic actually runs. That’s starting to change. AI is moving into eyecare workflows…

1 in 5 Americans May Have a Dangerous Toxin in Their Tap WaterOver 62 million Americans—roughly 1 in 5 people—may be exposed to potentially dangerous levels of nitrates in their tap water, a new report has shown. A compound of nitrogen and oxygen found naturally in air, water, soil and plants, nitrates become a health risk when rainfall causes nitrogen-rich fertilizers used in agriculture to leach into…

988 Hotline’s Launch Is Linked to Thousands of Fewer Suicide Deaths Among Teens and Young AdultsNearly 4,400 fewer U.S. teens and young adults died by suicide than projected in the first two-and-a-half years of the 988 mental health crisis hotline, a sign the program is working even as it faces long-term funding challenges. Suicide deaths among 15- to 23-year-olds were 11 percent lower than what researchers expected between July 2022—when…

Machine Analyzes Joint X-Rays About as Well as HumansA machine-learning system for analyzing rheumatoid arthritis (RA) patients' X-rays was able to produce Sharp/van der Heijde (SvdH) scores, the standard way to quantify joint space narrowing and bone erosions, with good accuracy when compared with human readers, researchers said.

EssilorLuxottica Reports Double-Digit Q1 Growth, Boosted by AI Glasses and Myopia Management PortfolioPARIS, France—EssilorLuxottica (Reuters: ESLX.PA) announced on Wednesday its first-quarter 2026 financial results, reporting consolidated revenue of €7,127 million. This marks the company's third consecutive quarter of double-digit growth, representing a 10.8 percent increase year-over-year at constant exchange rates compared with the first quarter of 2025, executives stated on the call. Leaders advised that both Professional…

Bausch + Lomb Releases Its 2025 Sustainability Impact Report, Outlines Progress in Environmental, Social and Governance PrioritiesVAUGHAN, Ontario—Global eye health leader Bausch + Lomb Corporation (NYSE/TSX: BLCO) announced the release of its 2025 Sustainability Impact Report, outlining the company’s progress against its environmental, social and governance priorities and introducing The Broader Perspective, the company’s sustainability framework designed to guide future action and accountability. The new framework highlights how Bausch + Lomb…

Innovative Eyewear Reports 78 Percent Sales Growth in Preliminary Q1 2026 ResultsMIAMI—Innovative Eyewear, Inc. (NASDAQ: LUCYW), the developer and manufacturer of smart eyewear under the Lucyd, Lucyd Armor, Reebok, Nautica, and Eddie Bauer brands, has announced its preliminary unaudited sales results for the first quarter ended March 31, 2026. The company achieved preliminary Q1 2026 sales of approximately $0.81 million, an increase of about 78 percent…

ABB Optical Group Launches 12th Annual Optometry Student ChallengeCORAL SPRINGS, Fla.—ABB Optical Group announced registration for its 12th Annual Optometry Student Challenge is now open for third- and fourth-year optometry students. Participants are invited to submit an abstract on a student-based case report or research study project focused on contact lenses.

American Academy of Optometry to Host 2026 Myopia Summit in St. LouisWINTER PARK, Fla.—The American Academy of Optometry has announced registration is now open for its 2026 Myopia Summit, a focused, one-day program designed to deliver practical, evidence-based strategies for modern myopia management.

Glaukos Receives Permanent J-code for Epioxa, a Treatment for KeratoconusALISO VIEJO, Calif.—Glaukos Corporation (NYSE: GKOS) has announced the U.S. Centers for Medicare and Medicaid Services (CMS) has assigned a unique, permanent Healthcare Common Procedure Coding System (HCPCS) J-code for Epioxa HD/Epioxa for the treatment of keratoconus.

CooperVision to Bring its 6th Asia-Pacific Myopia Management Symposium to Tokyo on May 10SINGAPORE—CooperVision, a global leader in myopia management, has announced the 6th edition of its annual Asia-Pacific Myopia Management Symposium (APMMS), which will take place in Tokyo, Japan at the Prince Park Tower on May 10, 2026.

Small Businesses Embrace AI to Stay CompetitiveWASHINGTON, D.C.—According to a recent white paper from the U.S. Chamber of Commerce Foundation and Hiring Our Heroes, a program designed to connect transitioning service members and veterans with full-time jobs, small businesses are using artificial intelligence (AI) to save time, streamline operations, and improve productivity. Artificial intelligence is moving quickly from experimentation to real-world…

Are Cancer-Screening Blood Tests Close to Prime Time?The vision of a single blood test that could screen for dozens of different cancers has tantalized oncologists for more than a decade. The science has advanced at a rapid clip: What began by analyzing levels of proteins in the blood has progressed to scrutinizing tiny amounts of DNA and feeding the data into algorithms…

Climate Extremes May Quietly Be Pushing Heart Disease Rates Higher: StudyHeatwaves, cold snaps and heavy rain do more than disrupt your day. They can quietly raise your risk of heart disease, according to a new report in the American Journal of Preventive Medicine.

MyEyeDr. Acquires Lumina Vision Partners, Expanding Presence With Doctor-Led Practices in SouthwestVIENNA, Va.—MyEyeDr. has announced the acquisition of Lumina Vision Partners, a 28-location practice group in Arizona and Texas. Founded in 2020, Lumina Vision Partners has established itself as one of the southwest's leading optometry platforms, known for partnering with premier independent practices and supporting doctors with resources, operational expertise and a patient-first philosophy. The transaction…

DigitalOptometrics Appoints Melanie Miller as Chief Commercial OfficerLAKE SUCCESS, N.Y.—DigitalOptometrics, a provider of remote comprehensive eye health and vision analysis systems, announced that Melanie Miller has been named chief commercial officer, effective immediately. According to the announcement, Miller is a proven commercial executive with over 20 years of leadership experience in driving revenue growth, building high-performance teams, and delivering sustainable business outcomes.…

CooperVision Advances Optometric Education Through Student Leadership ProgramROCHESTER, N.Y.—CooperVision recently hosted its 2026 Summit at the company’s global headquarters in Victor, N.Y., as part of its Student Contact Lens and Myopia Leadership Society, according to an announcement from the company.

New Weight Loss Research Questions Need for GLP-1 DrugsA new approach to weight loss research is challenging one of the biggest assumptions behind popular weight loss drugs: Are GLP-1s actually needed to achieve weight loss? In a new study published April 15 in the journal Molecular Metabolism, researchers tested a drug that targets two other hormones: GIP and glucagon.

U.S. Depression Rate Remains ElevatedThe percentage of U.S. adults who report currently having or being treated for depression was 19.1 percent in the first quarter of 2026, similar to the high mark of 20.0 percent recorded the preceding quarter and up nearly nine percentage points since the initial measurement in 2015. The current rate of 19.1 percent, among the…

EssilorLuxottica Joins Forces With the TFOS to Advance Ocular Surface HealthPARIS—EssilorLuxottica has announced a strategic partnership with the Tear Film & Ocular Surface Society (TFOS), an international non-profit organization dedicated to advancing research and education in ocular surface health.

Cherry Optical Lab Marks Five Years of Turning Plastic Waste Into PowerGREEN BAY, Wis.—Cherry Optical Lab has announced it is celebrating five years of reducing its manufacturing waste by turning its plastic waste, small plastic shavings known as “swarf,” into fuel for power plants.

Review of Ophthalmology: An Update on Monitoring Glaucoma at HomeOne of the major challenges in glaucoma care is the limited amount of data we collect in routine practice. Intraocular pressure may be measured only once every four to six months, while structural and functional testing is performed just a few times per year, and sometimes only once per year. As a result, clinical decision-making…

Pancreatic Cancer mRNA Vaccine Shows Lasting Results in an Early TrialDonna Gustafson had a harder time than usual shaking off the jet lag from her 22-hour journey from Florida to Australia. Two days into her trip, her skin took on the yellow hue of jaundice. Gustafson, who is now 72 and lives in Delray Beach, Florida, went to the emergency room for fluids, thinking she…

Severe Malaria in Kids Linked to Certain Cognitive, Academic Deficits Years LaterCerebral malaria and severe malarial anemia were linked to long-term cognitive and academic deficits in survivors of severe childhood malaria, according to a descriptive analysis in Uganda. In participants who were tested 4 to 15 years after their severe malaria episode, those with a history of cerebral malaria or severe malarial anemia had lower z…

Haag-Streit USA and Marco Lombart Announce Exclusive U.S. Distribution Agreement for Select TechnologyJACKSONVILLE, Fla.—Haag-Streit USA and Marco Lombart, an Advancing Eyecare company, today announce an exclusive U.S. distribution agreement for the Haag-Streit Lenstar 900 optical biometer and the Octopus 600 and Octopus 900 perimeters. The agreement designates Marco Lombart as the exclusive U.S. distributor for these two product lines, the companies stated, expanding access to clinically validated…

The Brien Holden Vision Institute and Review of Myopia Management Partner for Myopia Awareness Week Set for May 18-24SYDNEY, Australia—The Brien Holden Vision Institute (BHVI) and Review of Myopia Management have announced they are partnering once again for Myopia Awareness Week which runs May 18 to 24, building on the recent work by the International Myopia Institute (IMI), including its white paper on the role of light in myopia. The partnership aims to…

SUNY College of Optometry Foundation Marks 70 Years Shaping Vision Care and Research NationwideNEW YORK—For 70 years, the SUNY College of Optometry Foundation has played a leading role in shaping the field of optometry—advancing vision science, expanding access to care and helping train generations of eyecare professionals.

NECO Honors Its 2026 Scholarship RecipientsBOSTON—The New England College of Optometry (NECO) community celebrated its 2026 scholarship recipients on Thursday, April 16, 2026, with a ceremony recognizing their outstanding achievements in leadership, academic excellence, compassion and clinical expertise.

Harrow Iopidine 1% Receives Permanent J-Code Designation by the Centers for Medicare & Medicaid ServicesNASHVILLE, Tenn.—Harrow (Nasdaq: HROW) has announced that Iopidine 1% (apraclonidine hydrochloride ophthalmic solution) has been assigned a permanent J-Code (J2374) by the Centers for Medicare & Medicaid Services (CMS).

Review of Myopia Management: The Global Shift in Myopia Care From Correction to ManagementWhen I look back at the last decade in myopia management, what stands out most isn’t just the evolution of clinical guidelines; it is how the recognition of evidence-based therapies is reshaping the discussion between eyecare professionals and the families they serve. This shift is fostering trust and enabling more open, confident discussions about children’s…

Quit a GLP-1? Plan to Start Again? It's Not Recommended, But Plenty of People Do ItIt's quite common for people to start on GLP-1 drugs like Ozempic and Zepbound, especially as the diabetes and obesity treatments become more ubiquitous. They're designed to treat chronic conditions, so the medicines are intended for lifelong use; yet a high percentage of people who start them also quit.

Radiologists: Can You Detect Deepfake X-Rays?Generative artificial intelligence (AI) can now produce highly realistic x-ray images that experienced radiologists cannot distinguish from authentic scans. A study published in Radiology reported that neither clinicians nor multimodal AI models reliably identified these deepfakes. Researchers have warned that this introduces a risk for diagnostic errors and potential manipulation of clinical data and called…

First Phase of IEEPA Tariff Refund Process to Launch on April 20, Says U.S. Customs and Border ProtectionWASHINGTON D.C.—U.S. Customs and Border Protection (CBP) has announced that it is officially kicking of the first phase of an initiative that aims to streamline the submission and processing of refunds for tariffs imposed under the International Emergency Economic Powers Act (IEEPA). On April 20, 2026, those seeking refunds will be able to file through…

Tennessee Becomes 16th State to Expand Scope of Practice for ODsWASHINGTON, D.C.—Tennessee this month became the 16th state overall and the second this year to authorize optometrists to use ophthalmic lasers with the passage of Senate bill 2076 and its signed approval on April 14 by Governor Bill Lee. Coming just a month after a similar bill was passed in Kansas, the measure focuses primarily…

Foundation Fighting Blindness, Retina International World Congress to Host ‘United in Vision 2026’COLUMBIA, Md.—The Foundation Fighting Blindness has announced it will host the “United in Vision 2026” conference in partnership with Retina International, a global alliance of patient-led retina organizations, at the Fort Worth Convention Center on June 12-13, 2026.

Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eyecare Materials Recycled Through ONE by ONE ProgramVAUGHAN, Ontario—Bausch + Lomb Corporation has announced that its ONE by ONE Recycling program, created in collaboration with TerraCycle, has collected and recycled a total of 724,922 pounds of used contact lenses, eyecare and lens care materials in the U.S.

Glaukos Releases Its 2025 Sustainability Report, Highlighting Key MilestonesALISO VIEJO, Calif.—Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medtech company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced that it has published its 2025 Sustainability Report.

Review of Optometry: My Patient Has a Corneal Dystrophy… Now What?Many optometrists may see a case of corneal dystrophy daily; perhaps even several times per day. In many instances, the dystrophy is not visually significant. When the dystrophy impacts a patient’s quality of life, optometrists need to be prepared to discuss the pathology with the patient, as well as the risks of disease progression, and…

CooperVision Introduces ‘Made Better Promise’ Platform Beginning With MyDay Contact LensesROCHESTER, N.Y.—CooperVision has announced the introduction of its Made Better Promise—a new global sustainability platform focused on smarter, more sustainable choices. Built on years of CooperVision innovation in sustainability, the Made Better Promise is woven throughout the life of participating products, beginning with the MyDay daily disposable family of contact lenses. As part of the…

Weekly ER Visits for Tick Bites Reach Highest Level in Nearly a Decade. Will This Season Be Worse?Weekly visits to emergency rooms for tick bites are at the highest level since at least 2017, according to data from the Centers for Disease Control and Prevention (CDC). During the most recent week, 71 per 100,000 ER visits were due to tick bites, compared to the average of about 30 per 100,000 ER visits…

Life-Threatening Virus That Causes Vomiting and Diarrhea at High Levels in the U.S., CDC SaysRotavirus, a seasonal virus similar to influenza, has been rising across the U.S. since January. With infection rates higher now than this time last year, doctors have fresh concerns that declining vaccinations could lead to more severe illness and a higher surge in the coming years.

Zeiss Vision Care US Names Emi Cardarelli Vice President and Head of RetailHEBRON, Ky.—Zeiss Vision Care, a leading global manufacturer of eyeglass lenses and ophthalmic instruments, has announced the appointment of Emi Cardarelli as vice president and head of retail for Zeiss Vision Care US, effective April 6, 2026. Cardarelli brings more than 20 years of experience, including senior leadership expertise from the retail and wholesale industry…

PDS Optical to Host Generations of Veterans During Thunder Over Louisville 2026LOUISVILLE, Ky.—PDS Optical, a provider of prescription eyewear to veterans enrolled in The Department of Veterans Affairs (VA) health care system, is set to host more than 60 veterans and military survivors for a unique "Living History" assembly during Thunder Over Louisville.

Women In Optometry Celebrates 20th Anniversary, Debuts Refreshed BrandNEWARK, N.J.—Women In Optometry (WO), a national platform from Jobson Optical Group serving women eyecare professionals through news, features, events and digital content, is celebrating its 20th anniversary in 2026.

UNCP Breaks Ground on Future Home of New College of Optometric MedicinePEMBROKE, N.C.—The University of North Carolina at Pembroke announced it officially broke ground on construction of its new $96.8 million clinical sciences building on Friday, April 10, during a ceremony attended by university leaders, students, elected officials and community members.

Nearly 60 Percent Higher Risk of MS Seen for People With Diabetes in New StudyPeople with diabetes are significantly more likely—with nearly 60 percent higher odds—to develop multiple sclerosis (MS) than those without the metabolic disease, which is marked by high blood sugar levels, according to a new systematic review and meta-analysis. A significant association was also observed specifically between type 2 diabetes, the most common form of the…

Fielmann Group Creates U.S. Optometry Advisory Board, Tags NECO’s Dr. Howard Purcell as ChairmanHAMBURG, Germany and GREEN BAY, Wis.—Fielmann Group, a leading global vision care and eyewear provider, has announced the formation of a dedicated optometry advisory board for the U.S. market and has named Howard Purcell, OD, president and CEO of the New England College of Optometry (NECO), as chairman. The board will provide strategic guidance and…

Johnson & Johnson Reports Strong Q1 Earnings, Raises Its 2026 GuidanceNEW BRUNSWICK, N.J.—Johnson and Johnson (NYSE: JNJ) yesterday announced its first-quarter 2026 financial results and increased its 2026 guidance. The company reported Q1 sales growth of 9.9 percent year-over-year to $24.1 billion, with operational growth of 6.4 percent and adjusted operational growth of 5.3 percent. MedTech worldwide operational sales grew 7.7 percent, or 4.6 percent…

Lenstec Appoints Blake Michaels as Chief Executive OfficerST. PETERSBURG, Fla.—Lenstec announced it has appointed Blake Michaels as chief executive officer. In his new role, the company advised Michaels will focus on scaling operations, strengthening surgeon engagement and advancing Lenstec’s intraocular (IOL) portfolio.

American Academy of Optometry Opens Registration for Academy 2026 AnaheimWINTER PARK, Fla.—The American Academy of Optometry has announced that registration and housing are now open for Academy 2026 Anaheim, to be held September 30-October 3, 2026, at the Anaheim Convention Center in Anaheim, Calif.

Kering Eyewear Announces Record First Quarter ResultsPARIS—Kering Eyewear, part of the global luxury group Kering (KER.PA), reported its best-ever quarter with sales reaching €489 million, marking a 3 percent increase as reported and a 7 percent increase on a comparable basis year-over-year.

Adolescent and Young Adult Cancers Increase Risk of Developing Future CancersPeople who survived cancer as teens and young adults are at increased risk of developing cancer later in their lives, according to research from the Canadian Medical Association Journal. Approximately 16 percent of adolescent and young adult cancer survivors who stayed cancer-free for at least five years are at high risk, compared to about 12…

Huge Rates of Insurance Denials Get Overturned by Independent Review ExpertsPersistence in appealing denied health insurance claims resulted in overturned decisions between 30 percent and 78 percent of the time, when the case reached independent review organizations (IROs), an analysis of completed external appeals showed.

Record Registration Is Anticipated for Optometry’s Meeting in Phoenix, June 17-20PHOENIX—Preliminary registration figures for Optometry's Meeting in Phoenix, scheduled for June 17-20, 2026, indicate an anticipated record-setting year, according to the American Optometric Association. The organization noted an early increase in registrations among students and early-career doctors of optometry, particularly surrounding the AOA+ initiatives. According to the group, AOA+ student registration has already exceeded 2,600,…

Carrot Achieves Milestone With More Than 5 Million Visual Tests Performed in U.S. and CanadaBROOKLYN, N.Y.—Carrot, a North American visual diagnostic platform, has announced that more than 5 million tests have been completed using its visual testing platform across more than 2,400 eyecare clinics in the United States and Canada.

Southeast Asia, Western Pacific Eye Health Leaders Convene in Thailand Ahead of Global Summit for Eye HealthBANGKOK, Thailand—The International Agency for the Prevention of Blindness (IAPB) has announced that 70 government leaders convened at its South Asia and Western Pacific Regional Consultation meeting from April 1-2 in Bangkok, Thailand.

U.S. Measles Total Surpasses 1,700 CasesThe U.S. measles case count grew by 43 cases last week, reaching 1,714, the Centers for Disease Control and Prevention (CDC) said last week in its weekly update. The increase is much smaller than the 96-case jump of the previous week, and more than half of the new cases are in Utah.

Can Red Light Therapy Really Deliver a Beauty and Health Glow-Up? Here's the ScienceRed light therapy has become the latest ray of hope in the wellness industry. If you listen to wellness influencers, you might think there's nothing that red light therapy can't treat. But what's the science behind the hype?

FDA Approves Vabysmo for Extended Treatment of Macular Edema Due to Retinal Vein OcclusionSAN FRANCISCO—Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that it has received U.S. Food and Drug Administration (FDA) approval of Vabysmo (faricimab-svoa) for the treatment of macular edema due to retinal vein occlusion (RVO) beyond six months. RVO affects over a million Americans and often involves long-term intravitreal therapy…

FDA Approves Vabysmo for Extended Treatment of Macular Edema Due to Retinal Vein OcclusionSAN FRANCISCO—Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that it has received U.S. Food and Drug Administration (FDA) approval of Vabysmo (faricimab-svoa) for the treatment of macular edema due to retinal vein occlusion (RVO) beyond six months. RVO affects over a million Americans and often involves long-term intravitreal therapy…

SUNY Optometry Student Wins 2026 Innovator Award for Developing a New Way to Study for Board ExamsNEW YORK—Third-year doctor of optometry student, Jessica Luo, received the 2026 SUNY Optometry Student Innovator Award for her business plan Eye Q—a collaborative and adaptive learning platform to support and connect optometry students preparing for the NBEO exams.

Wake Forest University School of Medicine Students Provide Free Eye Health Screenings With Project SEEWINSTON‑SALEM, N.C.—Project Screening Eyes and Education (SEE), a student‑run initiative from Wake Forest University School of Medicine, is bringing free eye health screenings, prescription spectacles and ophthalmology consults directly to the community.

Comment on “Ocular surface inflammatory cytokines as a biomarker for retinopathy of prematurity” Eye, Published online: 11 May 2026; doi:10.1038/s41433-026-04411-6Comment on “Ocular surface inflammatory cytokines as a biomarker for retinopathy of prematurity”

Correction: Comparative effectiveness of varying hyperbaric oxygen protocols in the treatment of acute central retinal artery occlusion Eye, Published online: 11 May 2026; doi:10.1038/s41433-026-04492-3Correction: Comparative effectiveness of varying hyperbaric oxygen protocols in the treatment of acute central retinal artery occlusion

Advertising and large language models: a new frontier influencing medical practice Eye, Published online: 09 May 2026; doi:10.1038/s41433-026-04518-wAdvertising and large language models: a new frontier influencing medical practice

Comment on “Management and outcomes of ocular surface squamous neoplasia” by Höllhumer et al. (Eye, 2025) Eye, Published online: 09 May 2026; doi:10.1038/s41433-026-04409-0Comment on “Management and outcomes of ocular surface squamous neoplasia” by Höllhumer et al. (Eye, 2025)

Age, sex, and regional disparities in vision impairment burden among the population with diabetes: a 10-year trend analysis in Taiwan Eye, Published online: 09 May 2026; doi:10.1038/s41433-026-04519-9Age, sex, and regional disparities in vision impairment burden among the population with diabetes: a 10-year trend analysis in Taiwan

Anterior segment optical coherence tomography (AS-OCT) identification of anterior chamber hyper-reflective particles: a meta-analytic approach to methods and metrics Eye, Published online: 09 May 2026; doi:10.1038/s41433-026-04504-2Anterior segment optical coherence tomography (AS-OCT) identification of anterior chamber hyper-reflective particles: a meta-analytic approach to methods and metrics

Evaluating the effect of a new myopia control spectacle lens among children in Israel: 24-month results Eye, Published online: 09 May 2026; doi:10.1038/s41433-026-04455-8Evaluating the effect of a new myopia control spectacle lens among children in Israel: 24-month results

Artificial intelligence-assisted diagnosis and subtype differentiation of infectious keratitisEye, Published online: 08 May 2026; doi:10.1038/s41433-026-04491-4Artificial intelligence-assisted diagnosis and subtype differentiation of infectious keratitis

The fellow eye effectEye, Published online: 07 May 2026; doi:10.1038/s41433-026-04517-xThe fellow eye effect

Giant secondary limbal epithelial inclusion cyst following cataract surgeryEye, Published online: 07 May 2026; doi:10.1038/s41433-026-04494-1Giant secondary limbal epithelial inclusion cyst following cataract surgery

Microaneurysms in HIV-negative cytomegalovirus retinitis: an uncommon findingEye, Published online: 07 May 2026; doi:10.1038/s41433-026-04509-xMicroaneurysms in HIV-negative cytomegalovirus retinitis: an uncommon finding

Effect of low-cost direct ophthalmoscopy training on glaucoma disc assessment by allied ophthalmic personnel students: a controlled pre-post studyEye, Published online: 06 May 2026; doi:10.1038/s41433-026-04477-2Effect of low-cost direct ophthalmoscopy training on glaucoma disc assessment by allied ophthalmic personnel students: a controlled pre-post study

Iris electrocuted?Eye, Published online: 06 May 2026; doi:10.1038/s41433-026-04512-2Iris electrocuted?

When chronicity breeds complexity: gravitational fluid tracking and secondary choroidal neovascularisation in central serous chorioretinopathyEye, Published online: 06 May 2026; doi:10.1038/s41433-026-04507-zWhen chronicity breeds complexity: gravitational fluid tracking and secondary choroidal neovascularisation in central serous chorioretinopathy

Peripupillary iris atrophy as an anterior segment marker of diabetic retinopathyEye, Published online: 06 May 2026; doi:10.1038/s41433-026-04514-0Peripupillary iris atrophy as an anterior segment marker of diabetic retinopathy

Serratia marcescens infection in a meibomian cystEye, Published online: 06 May 2026; doi:10.1038/s41433-026-04497-ySerratia marcescens infection in a meibomian cyst

Multimodal deep learning prediction of treatment response to anti-vascular endothelial growth factor in diabetic macular oedemaEye, Published online: 06 May 2026; doi:10.1038/s41433-026-04505-1Multimodal deep learning prediction of treatment response to anti-vascular endothelial growth factor in diabetic macular oedema

Patient experience of and barriers to the eye examinationEye, Published online: 06 May 2026; doi:10.1038/s41433-026-04499-wPatient experience of and barriers to the eye examination

Genetic, clinical, and biological risk factors associated with optic nerve thinning in sickle cell diseaseEye, Published online: 06 May 2026; doi:10.1038/s41433-026-04318-2Genetic, clinical, and biological risk factors associated with optic nerve thinning in sickle cell disease

Twisted chains in retinopathy of prematurityEye, Published online: 05 May 2026; doi:10.1038/s41433-026-04513-1Twisted chains in retinopathy of prematurity

Comparison of the Nishida method and double-under muscle transposition in paralytic strabismusEye, Published online: 05 May 2026; doi:10.1038/s41433-026-04501-5Comparison of the Nishida method and double-under muscle transposition in paralytic strabismus

Chronic unilateral proptosis in a young womanEye, Published online: 05 May 2026; doi:10.1038/s41433-026-04510-4Chronic unilateral proptosis in a young woman

Ocular fingerprint of albinismEye, Published online: 05 May 2026; doi:10.1038/s41433-026-04503-3Ocular fingerprint of albinism

Anterior chamber hydatidosis: a rare occupational zoonosisEye, Published online: 05 May 2026; doi:10.1038/s41433-026-04498-xAnterior chamber hydatidosis: a rare occupational zoonosis

Comment on: ‘The role of blood pressure stability in diabetic retinopathy development’Eye, Published online: 05 May 2026; doi:10.1038/s41433-026-04502-4Comment on: ‘The role of blood pressure stability in diabetic retinopathy development’

A web of proliferation: fibrovascular membranes and the threat of silent traction in advanced PDREye, Published online: 05 May 2026; doi:10.1038/s41433-026-04511-3A web of proliferation: fibrovascular membranes and the threat of silent traction in advanced PDR

Agreements between 24-2 and 24-2 C test grids for chloroquine/hydroxychloroquine retinopathy patients and high-risk patientsEye, Published online: 05 May 2026; doi:10.1038/s41433-026-04462-9Agreements between 24-2 and 24-2 C test grids for chloroquine/hydroxychloroquine retinopathy patients and high-risk patients

Association between ocular manifestations and incident cardiovascular comorbidities in Ehlers Danlos SyndromeEye, Published online: 04 May 2026; doi:10.1038/s41433-026-04496-zAssociation between ocular manifestations and incident cardiovascular comorbidities in Ehlers Danlos Syndrome

OphthoEvidence: a model for rapid and trustworthy ophthalmology guidelinesEye, Published online: 04 May 2026; doi:10.1038/s41433-026-04473-6OphthoEvidence: a model for rapid and trustworthy ophthalmology guidelines

Bilateral streaky multifocal choroiditisEye, Published online: 04 May 2026; doi:10.1038/s41433-026-04493-2Bilateral streaky multifocal choroiditis

Optic nerve metastasis with secondary combined central retinal artery and vein occlusion from small cell lung cancerEye, Published online: 04 May 2026; doi:10.1038/s41433-026-04490-5Optic nerve metastasis with secondary combined central retinal artery and vein occlusion from small cell lung cancer

Posterior plate migration with tube retraction and exposureEye, Published online: 04 May 2026; doi:10.1038/s41433-026-04495-0Posterior plate migration with tube retraction and exposure

Risk of cerebrovascular and cardiovascular outcomes in patients with an ICD code for ocular migraineEye, Published online: 29 April 2026; doi:10.1038/s41433-026-04479-0Risk of cerebrovascular and cardiovascular outcomes in patients with an ICD code for ocular migraine

Multicentre study comparing ab-interno canaloplasty and trabecular micro-bypass stent in primary open-angle glaucomaEye, Published online: 28 April 2026; doi:10.1038/s41433-026-04483-4Multicentre study comparing ab-interno canaloplasty and trabecular micro-bypass stent in primary open-angle glaucoma

Posterior capsular folds causing monocular diplopia after cataract surgeryEye, Published online: 28 April 2026; doi:10.1038/s41433-026-04472-7Posterior capsular folds causing monocular diplopia after cataract surgery

Low-concentration atropine for management of myopia progression: does iris colour matter?Eye, Published online: 27 April 2026; doi:10.1038/s41433-026-04478-1Low-concentration atropine for management of myopia progression: does iris colour matter?

Bristol Eye Bank 40<sup>th</sup> anniversary – introducing corneal organ-culture storage to the United KingdomEye, Published online: 27 April 2026; doi:10.1038/s41433-026-04488-zBristol Eye Bank 40th anniversary – introducing corneal organ-culture storage to the United Kingdom

Long-term clinical outcomes in chronic ocular graft-versus-host disease: a retrospective cohort studyEye, Published online: 24 April 2026; doi:10.1038/s41433-026-04489-yLong-term clinical outcomes in chronic ocular graft-versus-host disease: a retrospective cohort study

Large-scale, real-world collection of refractive outcomes after cataract surgery through patient-mediated mobile photographyEye, Published online: 24 April 2026; doi:10.1038/s41433-026-04481-6Large-scale, real-world collection of refractive outcomes after cataract surgery through patient-mediated mobile photography

Peri-ocular soft tick infestation in a childEye, Published online: 24 April 2026; doi:10.1038/s41433-026-04475-4Peri-ocular soft tick infestation in a child

Infographic: Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitisEye, Published online: 23 April 2026; doi:10.1038/s41433-026-04451-yInfographic: Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis

Large colloid drusenEye, Published online: 23 April 2026; doi:10.1038/s41433-026-04484-3Large colloid drusen

UK consensus guidelines for tissue filler-induced vision lossEye, Published online: 23 April 2026; doi:10.1038/s41433-026-04470-9UK consensus guidelines for tissue filler-induced vision loss

Regional variation and trends in prostaglandin analogue prescribing for glaucoma in England 2019–2024Eye, Published online: 22 April 2026; doi:10.1038/s41433-026-04468-3Regional variation and trends in prostaglandin analogue prescribing for glaucoma in England 2019–2024

Bridge to vision: an unusual configuration of macular chorioretinal colobomasEye, Published online: 22 April 2026; doi:10.1038/s41433-026-04471-8Bridge to vision: an unusual configuration of macular chorioretinal colobomas

Transplant-associated bilateral fibrinous central serous chorioretinopathyEye, Published online: 22 April 2026; doi:10.1038/s41433-026-04476-3Transplant-associated bilateral fibrinous central serous chorioretinopathy

Rethinking phase III trials in retinal biosimilars: Do we still need them?Eye, Published online: 22 April 2026; doi:10.1038/s41433-026-04480-7Rethinking phase III trials in retinal biosimilars: Do we still need them?

Contact lenses with non‑refractive opaque features for paediatric myopia: a randomised, safety pilot trialEye, Published online: 22 April 2026; doi:10.1038/s41433-026-04469-2Contact lenses with non‑refractive opaque features for paediatric myopia: a randomised, safety pilot trial

Comparison of adverse renal events between ranibizumab and aflibercept in patients with diabetic macular oedema: A global network studyEye, Published online: 22 April 2026; doi:10.1038/s41433-026-04459-4Comparison of adverse renal events between ranibizumab and aflibercept in patients with diabetic macular oedema: A global network study

Ocular injuries in padel: findings from a survey on frequency, risk factors, and perceptions toward protective eyewearEye, Published online: 20 April 2026; doi:10.1038/s41433-026-04447-8Ocular injuries in padel: findings from a survey on frequency, risk factors, and perceptions toward protective eyewear

Out of sight: subconjunctival lens dislocationEye, Published online: 20 April 2026; doi:10.1038/s41433-026-04474-5Out of sight: subconjunctival lens dislocation

Giant plexiform neurofibroma and ocular abnormalities in a young femaleEye, Published online: 20 April 2026; doi:10.1038/s41433-026-04363-xGiant plexiform neurofibroma and ocular abnormalities in a young female

Tele-ophthalmology via UK Defence Medical Services Deployed Telemedicine: a review of referrals 2022–2025Eye, Published online: 18 April 2026; doi:10.1038/s41433-026-04465-6Tele-ophthalmology via UK Defence Medical Services Deployed Telemedicine: a review of referrals 2022–2025

Structural, functional and patient-reported 24-month outcomes of voretigene neparvovec in Portuguese patients with <i>RPE65</i>-associated diseaseEye, Published online: 17 April 2026; doi:10.1038/s41433-026-04467-4Structural, functional and patient-reported 24-month outcomes of voretigene neparvovec in Portuguese patients with RPE65-associated disease

The discarded lens: a molecular archive of ageingEye, Published online: 17 April 2026; doi:10.1038/s41433-026-04461-wThe discarded lens: a molecular archive of ageing

Morphologically similar bilateral subluxated cataracts in two siblings managed by lensectomy and glued intraocular lensEye, Published online: 17 April 2026; doi:10.1038/s41433-026-04466-5Morphologically similar bilateral subluxated cataracts in two siblings managed by lensectomy and glued intraocular lens

Retraction Note: Ultrasound biomicroscopy qualitative and quantitative signs of phacoantigenic uveitisEye, Published online: 16 April 2026; doi:10.1038/s41433-026-04458-5Retraction Note: Ultrasound biomicroscopy qualitative and quantitative signs of phacoantigenic uveitis

Diabetes and uveitis. A large cohort evaluation of the association between glycaemic control and incident undifferentiated anterior uveitis. (The DULCE Study)Eye, Published online: 16 April 2026; doi:10.1038/s41433-026-04464-7Diabetes and uveitis. A large cohort evaluation of the association between glycaemic control and incident undifferentiated anterior uveitis. (The DULCE Study)

Early real-world outcomes of aflibercept 8 mg in previously treated neovascular age-related macular degenerationEye, Published online: 14 April 2026; doi:10.1038/s41433-026-04425-0Early real-world outcomes of aflibercept 8 mg in previously treated neovascular age-related macular degeneration

Multimodal imaging for quantifying atrophic lesions in pathologic myopiaEye, Published online: 14 April 2026; doi:10.1038/s41433-026-04438-9Multimodal imaging for quantifying atrophic lesions in pathologic myopia

Timing of macular hole surgery among vitreoretinal surgeons in the UK: A national survey, review of literature and future directionEye, Published online: 14 April 2026; doi:10.1038/s41433-026-04449-6Timing of macular hole surgery among vitreoretinal surgeons in the UK: A national survey, review of literature and future direction

Comment on: ‘Phenotypic characterisation of enhanced S-cone syndrome—a multicentre case series analysis’Eye, Published online: 14 April 2026; doi:10.1038/s41433-026-04457-6Comment on: ‘Phenotypic characterisation of enhanced S-cone syndrome—a multicentre case series analysis’

Orbital IgG4-positive mucosa-associated lymphoid tissue lymphomaEye, Published online: 13 April 2026; doi:10.1038/s41433-026-04444-xOrbital IgG4-positive mucosa-associated lymphoid tissue lymphoma

Secondary extraocular extension of choroidal melanoma following primary photodynamic therapyEye, Published online: 13 April 2026; doi:10.1038/s41433-026-04295-6Secondary extraocular extension of choroidal melanoma following primary photodynamic therapy

Bilateral ocular leukemic infiltration as the first sign of Pre-B ALL relapseEye, Published online: 13 April 2026; doi:10.1038/s41433-026-04446-9Bilateral ocular leukemic infiltration as the first sign of Pre-B ALL relapse

Superior forniceal conjunctival epithelial cyst with a frog-belly configurationEye, Published online: 13 April 2026; doi:10.1038/s41433-026-04453-wSuperior forniceal conjunctival epithelial cyst with a frog-belly configuration

Large retinal cyst secondary to chronic rhegmatogenous retinal detachmentEye, Published online: 13 April 2026; doi:10.1038/s41433-026-04448-7Large retinal cyst secondary to chronic rhegmatogenous retinal detachment

A child with Wyburn-Mason syndrome presented with bilateral but asymmetrical retinal arteriovenous malformationsEye, Published online: 13 April 2026; doi:10.1038/s41433-026-04452-xA child with Wyburn-Mason syndrome presented with bilateral but asymmetrical retinal arteriovenous malformations

Posteriorly dislocated Cionni capsule tension ringEye, Published online: 13 April 2026; doi:10.1038/s41433-026-04445-wPosteriorly dislocated Cionni capsule tension ring

Web-Based Amblyopia Decision Support ToolThis Special Communication introduces an evidence-derived, web-based amblyopia decision support tool for eye care professionals.

Association of FOXC1 Duplications With Juvenile Open-Angle GlaucomaThis study investigated the prevalence and phenotype of FOXC1 duplications in 2 large glaucoma registries.

Periocular Leukoderma Associated With Topical TherapyThis case report discusses a patient with vitiligolike hypopigmentation and eczematous dermatitis associated with topical treatment with atropine and dorzolamide.

FOXC1 Duplications—New Mutations and Clinical Features in an Old Glaucoma GeneMuch has been learned about the genetic basis of juvenile open-angle glaucoma (JOAG) in the past 30 years. In this issue of JAMA Ophthalmology, Maxwell et al report discovering that duplications of the FOXC1 gene are a cause of JOAG. The FOXC1 gene encodes a transcription factor that regulates gene expression in the eye and…

Blunt Ocular Trauma in a 6-Year-Old ChildThis case report describes the ocular injury incurred after blunt ocular trauma secondary to a fishhook in the left eye of a male child, aged 6 years.

Intravitreal Interleukin 6 Inhibitors for Uveitic Macular EdemaThis Viewpoint discusses the results of a phase 1 study evaluating the intravitreal interleukin 6 inhibitor vamikibart for the treatment of uveitic macular edema.

Nonuniform Association of Genetic Risk Scores for Intraocular PressureThis genetic association study investigated whether or not the nonuniform association of genetic risk scores for intraocular pressure across quantiles of intraocular pressure are attributable to a distinct type of genetic interaction.

Different Predictors for Components of Spaceflight-Associated Neuro-Ocular SyndromeThis cohort study examined which preflight characteristics were associated with visual changes and clinically detectable optic disc edema in spaceflight-associated neuro-ocular syndrome.

Prevalence of the Predisposing Gene MBD4 for Uveal MelanomaThis case series evaluates results from germline target sequencing to assess the risk of developing uveal melanoma for carriers of the MBD4 monoallelic germline pathogenic variant.

Brolucizumab in the Treatment of Proliferative Diabetic RetinopathyThe CONDOR randomized clinical trial assesses the efficacy and safety of brolucizumab, 6 mg, compared with panretinal laser photocoagulation in eyes with proliferative diabetic retinopathy.

Rosettelike and Whorllike Lesions in Enhanced S-Cone SyndromeThis case report describes the potential phenotypic features in 2 patients with enhanced S-cone syndrome: rosettelike and whorllike lesions.

Financial ROI of Fellowship Training in OphthalmologyThis cross-sectional study evaluates the financial return on investment of ophthalmology fellowships by subspecialty and gender.

AS-OCT Imaging of River Water Granuloma in a ChildThis case report discusses a diagnosis of trematode granuloma in a child aged 8 years who presented with a painful red right eye after 2 weeks of river swimming.

Ophthalmoplegia and Ptosis After Cancer ImmunotherapyAn 82-year-old man presented with 4 months of fluctuating diagonal binocular diplopia and progressive bilateral ptosis. Examination in the strabismus clinic revealed variable ptosis and ophthalmoplegia in multiple gaze directions, with a large-angle esotropia and left hypotropia. What would you do next?

Evaluating Metrics Assessing Surgical Success in Patients Undergoing Cataract SurgeryThis cohort study assesses the validity and generalizability of 2024 Merit-Based Incentive Payment System (MIPS) measure 191, Cataracts: 20/40 or Better Visual Acuity Within 90 Days Following Cataract Surgery.

Early Treatment Response and 90-Day Vision in Microbial KeratitisThis cohort study among patients with microbial keratitis in the US and India identifies the presenting and early treatment response features associated with worse 90-day best-corrected visual acuity.

The Rise of Cultured Human Corneal Endothelial Cell TherapyWhile corneal transplant remains the standard treatment for endothelial disease, its limitations—including donor shortages exacerbated by stringent eligibility criteria, inequitable access to eye banking, and increased graft failure rates in high-risk populations—highlight the urgent need for alternatives.

Error in Byline and FiguresThe Original Investigation titled “Prevalence and Health Care Disparities of Retinal Conditions: A Meta-Analysis,” published on March 19, 2026, was corrected to fix an error in the byline and incomplete error bars in Figures 2 through 4; the correct name and degree is Durga S. Borkar, MD, MMCi, and the lower bounds of error bars…

Outer Retinal Disruption in a Young MaleA 17-year-old male with a 3-month history of bilateral blurred vision and photophobia presents with placoid lesions in both eyes and further vision loss in the right eye. What would you do next?

Cultured HCEC Injection for Endothelial Graft Failure After DSAEKThis case series investigates the changes in corneal clarity and endothelial function that are associated with the use of cultured human corneal endothelial cells in eyes with graft failure after Descemet stripping automated endothelial keratoplasty (DSAEK).